Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, daratumumab and hyaluronidase, and dexamethasone that is used for the treatment of plasma cell myeloma.

**Synonyms:** - Bortezomib-Daratumumab and Hyaluronidase-Dexamethasone Regimen - Bortezomib-Darzalex Faspro-Dexamethasone - Bortezomib-Dexamethasone Plus Daratumumab and Hyaluronidase - Bortezomib-Dexamethasone Plus Daratumumab and Hyaluronidase-fihj - Bortezomib/Daratumumab and Hyaluronidase-fihj/Dexamethasone Regimen - Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone - Bortezomib/Dexamethasone Plus Daratumumab and Hyaluronidase Regimen - Bortezomib/Dexamethasone Plus Darzalex Faspro - DVD (Daratumumab SC) - Dara (Daratumumab Subcutaneous)-VD Regimen - Dara-VD (SC Daratumumab) - Dara-Vd (SC daratumumab) - Daratumumab SC-Vd Regimen - Daratumumab Subcutaneous-Bortezomib-Dexamethasone Regimen - Daratumumab and Hyaluronidase-Vd Regimen - Daratumumab and Hyaluronidase-fihj/Bortezomib/Dexamethasone Regimen - Daratumumab and Hyaluronidase/Bortezomib/Dexamethasone Regimen - Daratumumab-Hyaluronidase/Bortezomib/Dexamethasone - Daratumumab/Hyaluronidase Bortezomib-Dexamethasone - Daratumumab/Hyaluronidase-Vd Regimen - Daratumumab/Recombinant Human Hyaluronidase/Bortezomib/Dexamethasone Regimen - Darzalex Faspro/Bortezomib/Dexamethasone Regimen - Darzalex Faspro/Velcade/Decadron Regimen - Velcade-Decadron Plus Darzalex Faspro Regimen